Logo

GATC Biotech Reorganizes into Three Divisions

Dec 04, 2014 | staff reporter

NEW YORK (GenomeWeb) – Constance, Germany-based sequencing services firm GATC Biotech announced on Dec. 2 a structural reorganization that divides its products and services into three divisions.

Sequencing Solutions will house the firm's Sanger sequencing and next-generation sequencing services, including its NGSelect and InView products. Customized Solutions will oversee consulting and project design services. Diagnostic Solutions will target opportunities to apply the firm's sequencing capabilities in areas such as oncology and companion diagnostics.  

The move will increase efficiency and flexibility, allowing GATC to secure and extend its market positions, the firm said in a statement.

 

Filed under

Business News
Sequencing
Companion Diagnostics
restructuring
GATC Biotech
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.